AU527318B2 - Trestatin a,b, and c (amino sugars) - Google Patents

Trestatin a,b, and c (amino sugars)

Info

Publication number
AU527318B2
AU527318B2 AU44028/79A AU4402879A AU527318B2 AU 527318 B2 AU527318 B2 AU 527318B2 AU 44028/79 A AU44028/79 A AU 44028/79A AU 4402879 A AU4402879 A AU 4402879A AU 527318 B2 AU527318 B2 AU 527318B2
Authority
AU
Australia
Prior art keywords
trestatin
amino sugars
sugars
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44028/79A
Other languages
English (en)
Other versions
AU4402879A (en
Inventor
Kiyoshi Ogawa
Yasuji Suhara
Kimihiro Watanabe
Kazuteru Yokose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU4402879A publication Critical patent/AU4402879A/en
Application granted granted Critical
Publication of AU527318B2 publication Critical patent/AU527318B2/en
Assigned to F. HOFFMANN-LA ROCHE AG reassignment F. HOFFMANN-LA ROCHE AG Alteration of Name(s) in Register under S187 Assignors: F. HOFFMANN-LA ROCHE & CO.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU44028/79A 1978-02-14 1979-02-07 Trestatin a,b, and c (amino sugars) Ceased AU527318B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14
GB583478 1978-02-14

Publications (2)

Publication Number Publication Date
AU4402879A AU4402879A (en) 1979-08-23
AU527318B2 true AU527318B2 (en) 1983-02-24

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44028/79A Ceased AU527318B2 (en) 1978-02-14 1979-02-07 Trestatin a,b, and c (amino sugars)

Country Status (26)

Country Link
US (1) US4273765A (enExample)
EP (1) EP0003616B1 (enExample)
JP (1) JPS54163511A (enExample)
AR (1) AR219150A1 (enExample)
AT (1) AT367451B (enExample)
AU (1) AU527318B2 (enExample)
CA (1) CA1121290A (enExample)
DE (2) DE2905649A1 (enExample)
DK (1) DK149599C (enExample)
ES (1) ES477653A1 (enExample)
FI (1) FI63062C (enExample)
FR (1) FR2416901A1 (enExample)
GR (1) GR72817B (enExample)
HU (1) HU181442B (enExample)
IE (1) IE47916B1 (enExample)
IL (1) IL56626A0 (enExample)
LU (1) LU80906A1 (enExample)
MC (1) MC1253A1 (enExample)
NL (1) NL7901182A (enExample)
NO (1) NO153011C (enExample)
NZ (1) NZ189625A (enExample)
PH (1) PH15084A (enExample)
PT (1) PT69218A (enExample)
SE (1) SE7901276L (enExample)
YU (1) YU41437B (enExample)
ZA (1) ZA79528B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056194B1 (en) 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
EP0559795B1 (en) * 1990-11-30 1995-12-27 Monoclonetics International, Inc. Methods for the diagnosis of chronic lower back and cervical pain
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
ATE343391T1 (de) * 2000-05-24 2006-11-15 Pfizer Behandlung von pansenacidose mit amylasehemmern
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP5115623B2 (ja) * 2008-04-11 2013-01-09 アステラス製薬株式会社 アミノ糖化合物及びその生産方法
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX389591B (es) 2014-08-29 2025-03-20 Tes Pharma S R L INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2019004321A (es) 2016-10-14 2019-06-12 Tes Pharma S R L Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
CN118496217A (zh) 2018-11-20 2024-08-16 Tes制药有限责任公司 α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NO153011C (no) 1986-01-02
DK149599C (da) 1987-06-01
IE790274L (en) 1979-08-14
NZ189625A (en) 1981-05-01
DE2962165D1 (en) 1982-03-25
EP0003616A2 (de) 1979-08-22
US4273765A (en) 1981-06-16
FI63062C (fi) 1983-04-11
AR219150A1 (es) 1980-07-31
FR2416901B1 (enExample) 1980-10-24
JPS54163511A (en) 1979-12-26
JPS643877B2 (enExample) 1989-01-23
SE7901276L (sv) 1979-08-15
ZA79528B (en) 1980-02-27
LU80906A1 (de) 1980-09-24
EP0003616B1 (de) 1982-02-24
HU181442B (en) 1983-07-28
AU4402879A (en) 1979-08-23
YU34879A (en) 1983-01-21
PH15084A (en) 1982-07-02
FI790486A7 (fi) 1979-08-15
DK61179A (da) 1979-08-15
IL56626A0 (en) 1979-05-31
FI63062B (fi) 1982-12-31
CA1121290A (en) 1982-04-06
EP0003616A3 (en) 1979-09-05
ES477653A1 (es) 1980-03-01
NL7901182A (nl) 1979-08-16
IE47916B1 (en) 1984-07-25
PT69218A (en) 1979-03-01
NO153011B (no) 1985-09-23
ATA108879A (de) 1981-11-15
GR72817B (enExample) 1983-12-06
FR2416901A1 (fr) 1979-09-07
DE2905649A1 (de) 1979-08-16
DK149599B (da) 1986-08-04
NO790469L (no) 1979-08-15
AT367451B (de) 1982-07-12
MC1253A1 (fr) 1980-01-14
YU41437B (en) 1987-06-30

Similar Documents

Publication Publication Date Title
AU527318B2 (en) Trestatin a,b, and c (amino sugars)
AU519122B2 (en) Peptides
AU518991B2 (en) Nozzles
AU4352279A (en) Nozzle assembly
AU3829078A (en) Collation
AU5156979A (en) Muffler
AU520927B2 (en) Recovering nickel
AU527467B2 (en) N,n:-bis(trifluoromethylsulphonyl) oxamides
AU524730B2 (en) 1-substituted thiomethyltriazolobenzodiazepines
AU516796B2 (en) Maltulose-containing syrups
AU525049B2 (en) Twin-gate type turnstile
AU4499579A (en) 3-0-(beta- d-glucuronopyranosyl) -soyasapogenol b
AU521411B2 (en) Pesticidal u.l.v. preparations
AU520355B2 (en) 2-arylamino-3,5dinitro-benzotrifluorides
AU507873B2 (en) 8b-ethyl-and 8b-methyl-4,5x-epoxymorphinan-6-compounds
AU507385B2 (en) Amino sugars
AU5076279A (en) Connecting piece
AU521689B2 (en) N,n:-bis((n-cyano-n:-alkynyl)methanimidamidyl)cystamines
AU4872179A (en) 2-amino-6-n,n-dimethylcarbamoyloxy-pyrimidines
AU531475B2 (en) Anthracylcine glycosides
AU4913279A (en) N-(3-trifluoromethyl-4-ethylphenyl)n:-n:-dimethylurea.
AU518768B2 (en) Gold extraction
AU522061B2 (en) 1-oxa-4-aza-2,6-disilacyclohexanes
AU520061B2 (en) Fungicidal alkoxyalkoxyacetyl acylalanines
AU519842B2 (en) Mononitro-n-alkyl-3, 4-xylidines